PPP2CB and atherosclerosis: Mechanistically, the study uncovered a novel interaction between PPP2CB and LOX-1 and demonstrated the downstream activation of the MAPK/ERK pathway, contributing new insights into the intracellular regulatory network of dyslipidemia-induced atherosclerosis.